The capacity expansion is expected to take place at Solvay’s Saint-Fons plant in France and will be fully operational in Q2-2019. With this move, the firm aims at improving the security of supply on three continents.
Lyon/France – Solvay is raising its European capacity of hydroquinone by 20 %, enhancing the security of supply on three continents. The move will also enable the firm to meet increasing demand for diphenol inhibitors used as additives by the monomer industry.
This capacity expansion at its plant in Saint-Fons, France is accomplished by debottlenecking the existing unit and follows a recent capacity increase in Zhenjiang, China. The project should be fully operational in Q2-2019.
Hydroquinone is key to process safety, transport and storage for monomer inhibition but also as a monomer itself in Polymer and Coatings applications.
The Saint-Fons Specialities plant in France is one of the 3 plants that makes up Solvay’s global inhibitor production network across Europe, North America and Asia, producing Hydroquinone; MEHQ (Monomethyl Ether of Hydroquinone); TBC (tertiary butyl-catechol) and PTZ (phenothiazine).